Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

453
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
453
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

1.2K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.2K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

34
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
34
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

239
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
239
In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

43
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
43
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH01:21

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

2.4K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crystallization and inhibition of monosodium urate monohydrate: advances in mechanistic understanding and perspectives for gout management.

Journal of materials chemistry. B·2025
Same author

Amorphous solid dispersion to facilitate the delivery of poorly water-soluble drugs: recent advances on novel preparation processes and technology coupling.

Expert opinion on drug delivery·2024
Same author

Metal-organic gels: recent advances in their classification, characterization, and application in the pharmaceutical field.

Journal of materials chemistry. B·2023
Same author

Switch between Cocrystal and Coamorphous Forms Depending on Thermal Modulation of Hot-Melt Extrusion.

Molecular pharmaceutics·2023
Same author

Recent advances on small molecular gels: formation mechanism and their application in pharmaceutical fields.

Expert opinion on drug delivery·2022
Same author

Cubosomes with surface cross-linked chitosan exhibit sustained release and bioavailability enhancement for vinpocetine.

RSC advances·2022

Related Experiment Video

Updated: Nov 1, 2025

A Freeze-Thawing Method to Prepare Chitosan-Polyvinyl alcohol Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
08:59

A Freeze-Thawing Method to Prepare Chitosan-Polyvinyl alcohol Hydrogels Without Crosslinking Agents and Diflunisal Release Studies

Published on: January 14, 2020

18.1K

Puerarin-Na Chelate Hydrate Simultaneously Improves Dissolution and Mechanical Behavior.

Hui Chen1, Zunting Pang2, Qiyang Qiao1

  • 1School of Pharmacy, China Pharmaceutical University, Nanjing 211198, PR China.

Molecular Pharmaceutics
|June 18, 2021
PubMed
Summary
This summary is machine-generated.

A novel PUE-Na chelate hydrate was developed, significantly improving the solubility and pharmaceutical properties of puerarin (PUE). This new form offers a promising candidate for developing PUE-based anti-hypertension drugs.

Keywords:
chelate hydratedissolutionflowabilitymechanical propertiespuerarin

More Related Videos

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

9.0K
Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
05:26

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications

Published on: April 13, 2022

3.6K

Related Experiment Videos

Last Updated: Nov 1, 2025

A Freeze-Thawing Method to Prepare Chitosan-Polyvinyl alcohol Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
08:59

A Freeze-Thawing Method to Prepare Chitosan-Polyvinyl alcohol Hydrogels Without Crosslinking Agents and Diflunisal Release Studies

Published on: January 14, 2020

18.1K
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
09:57

A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles

Published on: December 23, 2016

9.0K
Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
05:26

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications

Published on: April 13, 2022

3.6K

Area of Science:

  • Solid-state chemistry
  • Crystallography
  • Pharmaceutical sciences

Background:

  • Puerarin monohydrate (PUEM), the commercial form of puerarin (PUE), suffers from poor solubility, flowability, and mechanical properties.
  • These limitations hinder the development of effective PUE-based anti-hypertension therapies.

Purpose of the Study:

  • To develop a novel solid form of puerarin with enhanced pharmaceutical properties.
  • To investigate the crystal structure and physicochemical characteristics of the new solid form.

Main Methods:

  • Reactive crystallization was employed to synthesize the PUE-Na chelate hydrate.
  • Crystal structure analysis (X-ray diffraction) was performed to determine the molecular arrangement.
  • Na+ selective electrode confirmed complexation in aqueous solution.
  • Dissolution rate, tabletability, and flowability were evaluated and compared to PUEM.

Main Results:

  • PUE-Na chelate hydrate was successfully synthesized, featuring a unique tubular helix and DNA-like twisted helix crystal structure.
  • PUE-Na exhibited a ~38-fold increase in aqueous dissolution rate compared to PUEM.
  • The new form demonstrated enhanced tabletability and flowability.
  • Complexation in solution confirmed its chelate nature, distinct from organic metal salts.

Conclusions:

  • PUE-Na chelate hydrate represents a significant advancement over PUEM, offering vastly improved solubility and pharmaceutical properties.
  • The enhanced characteristics make PUE-Na a highly promising candidate for future development of puerarin-based anti-hypertension drugs.
  • This study highlights the potential of chelation strategies to overcome formulation challenges for natural products.